Yi Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi Sun has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Lan Sun
Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China; School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China
2 shared publications - Yu Ren
Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China
2 shared publications Gao-Bin Li
Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China; School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China
1 shared publicationHugh J. Field
Centre for Veterinary Science, Cambridge University Veterinary School, Madingley Road, Cambridge, CB3 0ES, United Kingdom, Department of Neurology, Glasgow University, Southern General Hospital, Glasgow, G51 4TF, United Kingdom
1 shared publication- Jiali Yuan
Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China
1 shared publication - Jiali Yuan
Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China; School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China; Yunnan Yunnanling Medicinal Resources Innovation Research Institute, Kunming, Yunnan, China
1 shared publication
Latest Publications
- 24 September 2025
- Published by Elsevier in Phytomedicine
- Vol. 148, 157297
Guipi Tang alleviates vascular dementia by regulating purine metabolism via gut microbiota-derived pantothenic acid
- 24 September 2025
- Published by Elsevier in Phytomedicine
- Vol. 148, 157297
Guipi Tang alleviates vascular dementia by regulating purine metabolism via gut microbiota-derived pantothenic acid
- 1 January 2025
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 53 (04) , 1155-1179
Total Saponins of Panax notoginseng Leaves Alleviate Vascular Dementia via the Gut–Brain Axis
Vascular dementia (VD) is the second most common type of dementia after Alzheimer’s disease (AD), and chronic cerebral hypoperfusion (CCH) is the main causative factor of VD. Previous reports have confirmed that there is a relationship between VD and gut microbiota, and that some plant-based foods can improve VD through the gut–brain axis (GBA). Panax notoginseng leaves are a specialty food in Yunnan, China, and saponin is its main bioactive component. In this study, we investigated the effects of the total saponins of Panax notoginseng leaves (TSPNL) on CCH-induced VD and their potential mechanisms. In this experiment, the model was replicated using bilateral common carotid artery occlusion (BCCAO) and divided into Sham, Model, TSPNL-L, TSPNL-H and Positive drug control. At the end of the treatment, behavior, brain-derived neurotrophic factor (BDNF), hypothalamic–pituitary–adrenal (HPA) axis-related indices, neuronal apoptosis-related indices, gut microbiota composition, and colon and brain pathology were tested. The results showed that TSPNL attenuated CCH-induced VD, promoted BDNF synthesis, and inhibited neuronal apoptosis. Predictions of network pharmacology and experiments demonstrated that these beneficial effects are mediated in part through BDNF-TrKB-PI3K/Akt signaling. In addition, TSPNL prevented intestinal dysbiosis by increasing the abundance of the probiotic Ligilactobacillus and decreasing the abundance of the deleterious bacterium Clostridia_ UCG_014_unclassified relative to the model group. TSPNL was also able to partially reverse intestinal barrier disruption and inhibit intestinal inflammation and the hyperactivation of the HPA axis. The results of this study support the conclusion that TSPNL has potential in the prevention of CCH-induced VD and warrants further investigation.
- 1 January 2025
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 53 (04) , 1155-1179
Total Saponins of Panax notoginseng Leaves Alleviate Vascular Dementia via the Gut–Brain Axis
Vascular dementia (VD) is the second most common type of dementia after Alzheimer’s disease (AD), and chronic cerebral hypoperfusion (CCH) is the main causative factor of VD. Previous reports have confirmed that there is a relationship between VD and gut microbiota, and that some plant-based foods can improve VD through the gut–brain axis (GBA). Panax notoginseng leaves are a specialty food in Yunnan, China, and saponin is its main bioactive component. In this study, we investigated the effects of the total saponins of Panax notoginseng leaves (TSPNL) on CCH-induced VD and their potential mechanisms. In this experiment, the model was replicated using bilateral common carotid artery occlusion (BCCAO) and divided into Sham, Model, TSPNL-L, TSPNL-H and Positive drug control. At the end of the treatment, behavior, brain-derived neurotrophic factor (BDNF), hypothalamic–pituitary–adrenal (HPA) axis-related indices, neuronal apoptosis-related indices, gut microbiota composition, and colon and brain pathology were tested. The results showed that TSPNL attenuated CCH-induced VD, promoted BDNF synthesis, and inhibited neuronal apoptosis. Predictions of network pharmacology and experiments demonstrated that these beneficial effects are mediated in part through BDNF-TrKB-PI3K/Akt signaling. In addition, TSPNL prevented intestinal dysbiosis by increasing the abundance of the probiotic Ligilactobacillus and decreasing the abundance of the deleterious bacterium Clostridia_ UCG_014_unclassified relative to the model group. TSPNL was also able to partially reverse intestinal barrier disruption and inhibit intestinal inflammation and the hyperactivation of the HPA axis. The results of this study support the conclusion that TSPNL has potential in the prevention of CCH-induced VD and warrants further investigation.